Literature DB >> 30404775

A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease.

Turner S Baker1, Kristyne J Gambino1, Lawrence Schriefer2, Jung-Yeon Lim1, Karyn Meltz Steinberg3,4, David C Fajgenbaum5, Alejandro Martín García-Sancho6, Minji Byun1,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30404775      PMCID： PMC6234382          DOI： 10.1182/bloodadvances.2018023911

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  18 in total

1.  Lymphoma in Castleman's disease, acute lymphocytic leukemia, adult T-cell leukemia and cutaneous T-cell lymphoma accompanied with high serum soluble Fas ligand levels.

Authors:  T Takubo; H Ohkura; T Kumura; K Ohta; T Yamane; M Hino; T Kamitani; N Tatsumi
Journal:  Haematologia (Budap)       Date:  2000

2.  Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

Authors:  Joao B Oliveira; Jack J Bleesing; Umberto Dianzani; Thomas A Fleisher; Elaine S Jaffe; Michael J Lenardo; Frederic Rieux-Laucat; Richard M Siegel; Helen C Su; David T Teachey; V Koneti Rao
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

Review 3.  New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

Authors:  David T Teachey
Journal:  Curr Opin Pediatr       Date:  2012-02       Impact factor: 2.856

4.  Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.

Authors:  Aude Magerus-Chatinet; Bénédicte Neven; Marie-Claude Stolzenberg; Cécile Daussy; Peter D Arkwright; Nina Lanzarotti; Catherine Schaffner; Sophie Cluet-Dennetiere; Filomeen Haerynck; Gérard Michel; Christine Bole-Feysot; Mohammed Zarhrate; Isabelle Radford-Weiss; Serge P Romana; Capucine Picard; Alain Fischer; Frédéric Rieux-Laucat
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

5.  Multicentric Castleman's disease with impaired lymphocytic apoptosis.

Authors:  Hiroyuki Minemura; Kazuhiko Ikeda; Yoshinori Tanino; Yuko Hashimoto; Takefumi Nikaido; Atsuro Fukuhara; Hiroshi Yokouchi; Suguru Sato; Mishie Tanino; Teruaki Oka; Akira Hebisawa; Hiroyuki Suzuki; Kazuei Ogawa; Yasuchika Takeishi; Mitsuru Munakata
Journal:  Allergol Int       Date:  2014-12-18       Impact factor: 5.836

6.  Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.

Authors:  Enrique M Ocio; Fermin M Sanchez-Guijo; Maria Diez-Campelo; Cristina Castilla; Oscar J Blanco; Dolores Caballero; Jesus F San Miguel
Journal:  Am J Hematol       Date:  2005-04       Impact factor: 10.047

7.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

8.  A Whole-Genome Analysis Framework for Effective Identification of Pathogenic Regulatory Variants in Mendelian Disease.

Authors:  Damian Smedley; Max Schubach; Julius O B Jacobsen; Sebastian Köhler; Tomasz Zemojtel; Malte Spielmann; Marten Jäger; Harry Hochheiser; Nicole L Washington; Julie A McMurry; Melissa A Haendel; Christopher J Mungall; Suzanna E Lewis; Tudor Groza; Giorgio Valentini; Peter N Robinson
Journal:  Am J Hum Genet       Date:  2016-08-25       Impact factor: 11.025

Review 9.  HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Authors:  David C Fajgenbaum; Frits van Rhee; Christopher S Nabel
Journal:  Blood       Date:  2014-03-12       Impact factor: 22.113

10.  Clinical features and outcomes in patients with human immunodeficiency virus-negative, multicentric Castleman's disease: a single medical center experience.

Authors:  Seyoung Seo; Changhoon Yoo; Dok Hyun Yoon; Shin Kim; Jung Sun Park; Chan-Sik Park; Jooryung Huh; Cheolwon Suh
Journal:  Blood Res       Date:  2014-12-23
View more
  7 in total

1.  Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up.

Authors:  Wanying Liu; Qingqing Cai; Tiantian Yu; Paolo Strati; Frederick B Hagemeister; Qiongli Zhai; Mingzhi Zhang; Ling Li; Xiaosheng Fang; Jianyong Li; Ruifang Sun; Shanxiang Zhang; Hanjin Yang; Zhaoming Wang; Wenbian Qian; Noriko Iwaki; Yasuharu Sato; Eric Oksenhendler; Zijun Y Xu-Monette; Ken H Young; Li Yu
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

Review 2.  Castleman disease.

Authors:  Antonino Carbone; Margaret Borok; Blossom Damania; Annunziata Gloghini; Mark N Polizzotto; Raj K Jayanthan; David C Fajgenbaum; Mark Bower
Journal:  Nat Rev Dis Primers       Date:  2021-11-25       Impact factor: 65.038

3.  Transcriptome and unique cytokine microenvironment of Castleman disease.

Authors:  Anna Wing; Jason Xu; Wenzhao Meng; Aaron M Rosenfeld; Elizabeth Y Li; Gerald Wertheim; Michele Paessler; Adam Bagg; Dale Frank; Kai Tan; David T Teachey; Megan S Lim; Eline Luning Prak; David C Fajgenbaum; Vinodh Pillai
Journal:  Mod Pathol       Date:  2021-10-22       Impact factor: 8.209

4.  Histologic and Laboratory Characteristics of Symptomatic and Asymptomatic Castleman Disease in the Pediatric Population.

Authors:  Karen M Chisholm; Mark D Fleming
Journal:  Am J Clin Pathol       Date:  2020-05-05       Impact factor: 2.493

5.  DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cells.

Authors:  Jung-Yeon Lim; Sascha H Duttke; Turner S Baker; Jihye Lee; Kristyne J Gambino; Nicholas J Venturini; Jessica Sook Yuin Ho; Simin Zheng; Yesai S Fstkchyan; Vinodh Pillai; David C Fajgenbaum; Ivan Marazzi; Christopher Benner; Minji Byun
Journal:  J Exp Med       Date:  2021-05-10       Impact factor: 17.579

6.  An Improved Phenotype-Driven Tool for Rare Mendelian Variant Prioritization: Benchmarking Exomiser on Real Patient Whole-Exome Data.

Authors:  Valentina Cipriani; Nikolas Pontikos; Gavin Arno; Panagiotis I Sergouniotis; Eva Lenassi; Penpitcha Thawong; Daniel Danis; Michel Michaelides; Andrew R Webster; Anthony T Moore; Peter N Robinson; Julius O B Jacobsen; Damian Smedley
Journal:  Genes (Basel)       Date:  2020-04-23       Impact factor: 4.096

Review 7.  A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.

Authors:  Alexandra Butzmann; Jyoti Kumar; Kaushik Sridhar; Sumanth Gollapudi; Robert S Ohgami
Journal:  Biology (Basel)       Date:  2021-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.